Bullet Biotechnology's Series A - II Round

Bullet Biotechnology raised a round of funding on June 11, 2013. Investors include Accel.

Bullet Bio is developing an active immunotherapy to stimulate a person's own immune system to fight disease. The company's product trains the immune system to target a unique marker present on all B c…

Articles about Bullet Biotechnology's Series A - II Round: